Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig M Crews

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
ACS Chemical Biology|June 24, 2022
Targeted Degradation of mRNA Decapping Enzyme DcpS by a VHL-Recruiting PROTACJake C Swartzel, Michael J Bond, Andreas P Pintado-Urbanc, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancerKanak Raina, Jing Lu, Yimin Qian, et al.
Cell Chemical Biology|November 14, 2017
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case StudyGeorge M Burslem, Blake E Smith, Ashton C Lai, et al.
Angewandte Chemie (International Ed. in English)|June 18, 2015
Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic TaggingJeffrey L Gustafson, Taavi K Neklesa, Carly S Cox, et al.
Journal of Medicinal Chemistry|July 11, 2017
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1Andrew P Crew, Kanak Raina, Hanqing Dong, et al.
The Journal of Clinical Investigation|March 5, 2019
BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironmentSujan Piya, Hong Mu, Seemana Bhattacharya, et al.
Nature Chemical Biology|October 20, 2014
Pharmacological targeting of the pseudokinase Her3Ting Xie, Sang Min Lim, Kenneth D Westover, et al.
Leukemia|March 3, 2021
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphomaWarren Fiskus, Christopher P Mill, Dimuthu Perera, et al.
Leukemia|March 28, 2018
Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myelomaXiaohui Zhang, Hans C Lee, Fazal Shirazi, et al.
Blood|April 27, 2019
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1Christopher P Mill, Warren Fiskus, Courtney D DiNardo, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
ACS Chemical Biology|June 24, 2022
Targeted Degradation of mRNA Decapping Enzyme DcpS by a VHL-Recruiting PROTACJake C Swartzel, Michael J Bond, Andreas P Pintado-Urbanc, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2016
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancerKanak Raina, Jing Lu, Yimin Qian, et al.
Cell Chemical Biology|November 14, 2017
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case StudyGeorge M Burslem, Blake E Smith, Ashton C Lai, et al.
Angewandte Chemie (International Ed. in English)|June 18, 2015
Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic TaggingJeffrey L Gustafson, Taavi K Neklesa, Carly S Cox, et al.
Journal of Medicinal Chemistry|July 11, 2017
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1Andrew P Crew, Kanak Raina, Hanqing Dong, et al.
The Journal of Clinical Investigation|March 5, 2019
BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironmentSujan Piya, Hong Mu, Seemana Bhattacharya, et al.
Nature Chemical Biology|October 20, 2014
Pharmacological targeting of the pseudokinase Her3Ting Xie, Sang Min Lim, Kenneth D Westover, et al.
Leukemia|March 3, 2021
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphomaWarren Fiskus, Christopher P Mill, Dimuthu Perera, et al.
Leukemia|March 28, 2018
Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myelomaXiaohui Zhang, Hans C Lee, Fazal Shirazi, et al.
Blood|April 27, 2019
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1Christopher P Mill, Warren Fiskus, Courtney D DiNardo, et al.
Pageof 16